X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Cipla - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs CIPLA - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

CIPLA 
   Change

Cipla is one of the largest pharma companies in the domestic market and has presence in formulations and bulk drugs manufacturing. All the bulk drug manufacturing facilities of the company have been approved by various authorities including the US FD... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS CIPLA J.B.CHEMICALS/
CIPLA
 
P/E (TTM) x 13.9 43.7 31.9% View Chart
P/BV x 2.2 3.6 61.2% View Chart
Dividend Yield % 0.2 0.4 49.3%  

Financials

 J.B.CHEMICALS   CIPLA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
CIPLA
Mar-17
J.B.CHEMICALS/
CIPLA
5-Yr Chart
Click to enlarge
High Rs318622 51.1%   
Low Rs200458 43.5%   
Sales per share (Unadj.) Rs148.0181.9 81.4%  
Earnings per share (Unadj.) Rs19.112.9 148.3%  
Cash flow per share (Unadj.) Rs23.929.3 81.7%  
Dividends per share (Unadj.) Rs0.502.00 25.0%  
Dividend yield (eoy) %0.20.4 52.2%  
Book value per share (Unadj.) Rs128.9155.7 82.8%  
Shares outstanding (eoy) m84.82804.51 10.5%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x1.73.0 58.9%   
Avg P/E ratio x13.642.0 32.3%  
P/CF ratio (eoy) x10.818.4 58.7%  
Price / Book Value ratio x2.03.5 57.9%  
Dividend payout %2.615.5 16.9%   
Avg Mkt Cap Rs m21,951434,516 5.1%   
No. of employees `0002.723.0 11.9%   
Total wages/salary Rs m1,84126,338 7.0%   
Avg. sales/employee Rs Th4,590.96,349.1 72.3%   
Avg. wages/employee Rs Th673.41,143.0 58.9%   
Avg. net profit/employee Rs Th592.1449.3 131.8%   
INCOME DATA
Net Sales Rs m12,551146,302 8.6%  
Other income Rs m5422,287 23.7%   
Total revenues Rs m13,093148,589 8.8%   
Gross profit Rs m2,05524,758 8.3%  
Depreciation Rs m41213,229 3.1%   
Interest Rs m961,594 6.0%   
Profit before tax Rs m2,08812,222 17.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-70 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4691,798 26.1%   
Profit after tax Rs m1,61910,354 15.6%  
Gross profit margin %16.416.9 96.7%  
Effective tax rate %22.514.7 152.7%   
Net profit margin %12.97.1 182.2%  
BALANCE SHEET DATA
Current assets Rs m7,77887,370 8.9%   
Current liabilities Rs m4,35833,081 13.2%   
Net working cap to sales %27.237.1 73.4%  
Current ratio x1.82.6 67.6%  
Inventory Days Days5587 62.9%  
Debtors Days Days8062 128.4%  
Net fixed assets Rs m5,713111,567 5.1%   
Share capital Rs m1701,609 10.5%   
"Free" reserves Rs m10,547123,645 8.5%   
Net worth Rs m10,937125,254 8.7%   
Long term debt Rs m036,454 0.0%   
Total assets Rs m15,574209,532 7.4%  
Interest coverage x22.88.7 263.3%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x0.80.7 115.4%   
Return on assets %11.05.7 193.0%  
Return on equity %14.88.3 179.0%  
Return on capital %20.08.5 234.9%  
Exports to sales %48.734.2 142.4%   
Imports to sales %7.18.3 84.9%   
Exports (fob) Rs m6,11550,050 12.2%   
Imports (cif) Rs m88912,203 7.3%   
Fx inflow Rs m6,16951,066 12.1%   
Fx outflow Rs m1,28517,678 7.3%   
Net fx Rs m4,88433,388 14.6%   
CASH FLOW
From Operations Rs m1,39723,824 5.9%  
From Investments Rs m-320-13,127 2.4%  
From Financial Activity Rs m-1,196-13,239 9.0%  
Net Cashflow Rs m-102-2,478 4.1%  

Share Holding

Indian Promoters % 55.4 16.0 346.3%  
Foreign collaborators % 0.3 20.8 1.4%  
Indian inst/Mut Fund % 3.4 12.2 27.8%  
FIIs % 3.9 23.7 16.5%  
ADR/GDR % 0.0 1.1 -  
Free float % 37.0 26.2 141.2%  
Shareholders   30,437 161,166 18.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   JUBILANT LIFE SCIENCES  DR. DATSONS LABS  ELDER PHARMA  GSK PHARMA  PANACEA BIOTECH  

Compare J.B.CHEMICALS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Infosys Woes, Insurance IPOs and Top Stocks in Action(Pre-Open)

On Monday, the share markets in India slumped in the final hours of trade and finished the day in red.The BSE Sensex closed lower by 266 points to end at 31,259.

Related Views on News

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Cipla: Weak Quarter, Positive Triggers Ahead (Quarterly Results Update - Detailed)

Sep 19, 2016

Cipla has announced its results for the June quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Aug 21, 2017 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 8-QTR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS